Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Licenses Array IP to Baylor for CLIA-based CGH Services

NEW YORK (GenomeWeb News) — Baylor College of Medicine has licensed a number of patents from Affymetrix to perform certain microarray services in Clinical Laboratory Improvement Amendments environments, the groups said today.
 
Under the terms of the deal, scientists at Baylor’s Department of Molecular and Human Genetics will have non-exclusive rights to use Affy’s patents for comparative genomics hybridization microarray services.
 
Arthur Beaudet, chair of Baylor’s DMHG, said the scientists will use the technology “to identify specific genetic abnormalities in many children that have developmental disabilities with previously unknown causes.”
 
The DMHG conducts research in a wide variety of fields, including functional genomics, sequencing, human and mammal genome studies and numerous diseases.
 
Financial details or the duration of the agreement were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.